Receiving at least one ASCT | Receiving consolidation phase treatment | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Coeff. | S.E. | P > |z| | 95 % | C.I. | Coeff. | S.E. | P > |z| | 95 % | C.I. | |
Age > 50 years | 0.2192 | 0.2005 | 0.2740 | -0.1738 | 0.6122 | -1.1036 | 0.3268 | 0.0010 | -1.7442 | -0.4631 |
Male sex | -0.3034 | 0.1756 | 0.0840 | -0.6476 | 0.0408 | 0.1046 | 0.1739 | 0.5470 | -0.2361 | 0.4454 |
HB ≤ 10.5 g/dL | -0.1751 | 0.1809 | 0.3330 | -0.5296 | 0.1795 | 0.0556 | 0.1851 | 0.7640 | -0.3072 | 0.4183 |
Plts ≤ 150 x109/L | -0.1085 | 0.2592 | 0.6750 | -0.6166 | 0.3995 | 0.3935 | 0.3059 | 0.1980 | -0.2060 | 0.9930 |
Crea > 1.2 μmol/dL | 0.0577 | 0.2220 | 0.7950 | -0.3774 | 0.4927 | 0.0155 | 0.2167 | 0.9430 | -0.4092 | 0.4402 |
LDH > 190 U/L | 0.3097 | 0.2220 | 0.1630 | -0.1254 | 0.7448 | 0.3123 | 0.2309 | 0.1760 | -0.1403 | 0.7648 |
ISS > 1 | 0.2584 | 0.1864 | 0.1660 | -0.1070 | 0.6238 | 0.1231 | 0.1770 | 0.4870 | -0.2238 | 0.4700 |
IgA isotype | 0.0031 | 0.2062 | 0.9880 | -0.4011 | 0.4073 | -0.1299 | 0.2136 | 0.5430 | -0.5485 | 0.2887 |
Del(13q) | 0.0375 | 0.1765 | 0.8320 | -0.3086 | 0.3835 | -0.0420 | 0.1722 | 0.8070 | -0.3795 | 0.2954 |
T(4;14) | -0.1485 | 0.2099 | 0.4790 | -0.5599 | 0.2628 | 0.3715 | 0.2321 | 0.1100 | -0.0835 | 0.8264 |
Del(17p) | -0.2640 | 0.3039 | 0.3850 | -0.8597 | 0.3317 | 0.4939 | 0.4040 | 0.2220 | -0.2979 | 1.2858 |
Arm A | 0.2628 | 0.1672 | 0.1160 | -0.0649 | 0.5906 | 0.0036 | 0.1657 | 0.9830 | -0.3212 | 0.3284 |
CR at induction | 0.1073 | 0.2476 | 0.6650 | -0.3781 | 0.5926 | |||||
Constant | 0.7531 | 0.2990 | 0.0120 | 0.1670 | 1.3392 | 1.3012 | 0.4762 | 0.0060 | 0.3678 | 2.2345 |